Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retinitis Pigmentosa 2”

50 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 50 results

Not applicableLooking for participantsNCT06887348
What this trial is testing

Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

Who this might be right for
MelanomaMetastatic MelanomaAdvanced Solid Tumor+1 more
Replimune Inc. 50
Not applicableEnrolling By InvitationNCT05921162
What this trial is testing

A Long-Term Follow-Up Study in Subjects Who Received vMCO-I Administered Via Intravitreal Injection

Who this might be right for
Retinitis PigmentosaRetinal DiseaseRetinal Degeneration
Nanoscope Therapeutics Inc. 11
Not applicableStudy completedNCT03840603
What this trial is testing

Impact on PCT+ FilmArray RP2 Plus Use in LRTI Suspicion in Emergency Department

Who this might be right for
Respiratory Tract Infections
BioMérieux 444
Testing effectiveness (Phase 2)UnknownNCT04864496
What this trial is testing

Effects of Treatment With N- Acetylcysteine on Visual Outcomes in Patients With Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
Shahid Beheshti University of Medical Sciences 30
Not applicableStudy completedNCT03626207
What this trial is testing

Development of Visual Function Evaluation Method (2)

Who this might be right for
Retinitis Pigmentosa
Astellas Pharma Inc 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT06646289
What this trial is testing

A Follow-on Study for Second-Eye Treatment for Participants Previously Treated With Gene Therapy for X-Linked Retinitis Pigmentosa (XLRP)

Who this might be right for
X-Linked Retinitis Pigmentosa
Janssen Research & Development, LLC 24
Testing effectiveness (Phase 2)Ended earlyNCT05085964
What this trial is testing

An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosa

Who this might be right for
Retinitis PigmentosaUsher Syndrome Type 2
Laboratoires Thea 21
Testing effectiveness (Phase 2)Ended earlyNCT05733611
What this trial is testing

RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC

Who this might be right for
Refractory Metastatic Colorectal CancerpMMRMSS
Replimune Inc. 5
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07282457
What this trial is testing

Prospective, Randomized, Sham-controlled, Dose-finding I/II Trial of Safety and Efficacy of Modified Optogenetic Gene Therapy (ZM-02 Injection)

Who this might be right for
Retinitis Pigmentosa (RP)
Zhongmou Therapeutics 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07059611
What this trial is testing

Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaEsophageal AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Abramson Cancer Center at Penn Medicine 34
Testing effectiveness (Phase 2)Looking for participantsNCT04278131
What this trial is testing

BS01 in Patients With Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
Bionic Sight LLC 20
Not applicableStudy completedNCT01325506
What this trial is testing

Effectiveness of Open and Robotic Prostatectomy

Who this might be right for
Prostate Cancer
Beth Israel Deaconess Medical Center 677
Testing effectiveness (Phase 2)Study completedNCT04604899
What this trial is testing

Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
jCyte, Inc 30
Not applicableStudy completedNCT00001347
What this trial is testing

Study of Usher Syndromes, Type 1 and Type 2

Who this might be right for
Retinitis Pigmentosa
National Eye Institute (NEI) 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT04517149
What this trial is testing

4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)

Who this might be right for
X-Linked Retinitis Pigmentosa
4D Molecular Therapeutics 21
Testing effectiveness (Phase 2)Study completedNCT02110225
What this trial is testing

A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP)

Who this might be right for
Retinitis Pigmentosa
Dompé Farmaceutici S.p.A 50
Testing effectiveness (Phase 2)Study completedNCT01530659
What this trial is testing

Retinal Imaging in CNTF -Releasing Encapsulated Cell Implant Treated Patients for Early-stage Retinitis Pigmentosa

Who this might be right for
Retinitis PigmentosaUsher Syndrome Type 2Usher Syndrome Type 3
Neurotech Pharmaceuticals 22
Not applicableLooking for participantsNCT06092346
What this trial is testing

A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders

Who this might be right for
AMPD3, OMIM*102772, AMP Deaminase DeficiencyAK1, OMIM *103000, Adenylate Kinase DeficiencyAMPD1, OMIM *102770, Myopathy Due to Myoadenylate Deaminase Deficiency+25 more
National Human Genome Research Institute (NHGRI)
Not applicableLooking for participantsNCT06982417
What this trial is testing

InsightRP2 Registry

Who this might be right for
RP2-associated Retinitis PigmentosaX-Linked Retinitis Pigmentosa (XLRP)Retinitis Pigmentosa 2
University of Göttingen 200
Large-scale testing (Phase 3)Study completedNCT05194124
What this trial is testing

Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Participants With Specific Gene Defects in the MC4R Pathway

Who this might be right for
Bardet-Biedl SyndromePOMC Deficiency
Rhythm Pharmaceuticals, Inc. 19
Load More Results
999